GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Indegene Ltd (BOM:544172) » Definitions » Other Gross PPE

Indegene (BOM:544172) Other Gross PPE : ₹1,349 Mil (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Indegene Other Gross PPE?

Indegene's Other Gross PPE for the quarter that ended in Mar. 2025 was ₹1,349 Mil.

Indegene's quarterly Other Gross PPE declined from Sep. 2024 (₹1,107 Mil) to Dec. 2024 (₹0 Mil) but then increased from Dec. 2024 (₹0 Mil) to Mar. 2025 (₹1,349 Mil).

Indegene's annual Other Gross PPE increased from Mar. 2023 (₹0 Mil) to Mar. 2024 (₹1,144 Mil) and increased from Mar. 2024 (₹1,144 Mil) to Mar. 2025 (₹1,349 Mil).


Indegene Other Gross PPE Historical Data

The historical data trend for Indegene's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indegene Other Gross PPE Chart

Indegene Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Other Gross PPE
- - - 1,144.00 1,349.00

Indegene Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 1,144.00 - 1,107.00 - 1,349.00

Indegene Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Indegene Business Description

Traded in Other Exchanges
Address
Outer Ring Road, Aspen Block G4, 3rd Floor, Manyata Embassy Business Park, Nagawara, Bengaluru, KA, IND, 560045
Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations of life sciences companies. The company segment includes Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment.

Indegene Headlines

No Headlines